RESULTS	On month 12 , both BZA/CE doses and CE/MPA significantly improved time to fall asleep and sleep disturbance ( P < 0.05 vs. placebo ) ; BZA 20 mg/CE 0.625 mg and CE/MPA also showed significant improvements in sleep adequacy and sleep problem indices I and II ( P < 0.01 vs placebo ) .\